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Abstract
Alagille syndrome is an autosomal dominant disorder involving bile duct paucity and cholestasis in addition to cardiac,
skeletal, ophthalmologic, renal and vascular manifestations. Mutations in JAG1, encoding a ligand in the Notch signaling
pathway, are found in 95% of patients meeting clinical criteria for Alagille syndrome. In order to define the role of Jag1 in
the bile duct developmental abnormalities seen in ALGS, we previously created a Jag1 conditional knockout mouse model.
Mice heterozygous for the Jag1 conditional and null alleles demonstrate abnormalities in postnatal bile duct growth and
remodeling, with portal expansion and increased numbers of malformed bile ducts. In this study we report the results of
microarray analysis and identify genes and pathways differentially expressed in the Jag1 conditional/null livers as compared
with littermate controls. In the initial microarray analysis, we found that many of the genes up-regulated in the Jag1
conditional/null mutant livers were related to extracellular matrix (ECM) interactions, cell adhesion and cell migration. One
of the most highly up-regulated genes was Ddr1, encoding a receptor tyrosine kinase (RTK) belonging to a large RTK family.
We have found extensive co-localization of Jag1 and Ddr1 in bile ducts and blood vessels in postnatal liver. In addition, co-
immunoprecipitation data provide evidence for a novel protein interaction between Jag1 and Ddr1. Further studies will be
required to define the nature of this interaction and its functional consequences, which may have significant implications
for bile duct remodeling and repair of liver injury.
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Introduction
Alagille syndrome (ALGS) is an autosomal dominant disorder
involving bile duct paucity and cholestasis in addition to cardiac,
skeletal, ophthalmologic, renal and vascular manifestations.
Mutations in JAG1, encoding a ligand in the Notch signaling
pathway, are found in 95% of patients meeting clinical criteria for
ALGS, and a small number of patients have mutations in
NOTCH2 [1–3]. In order to define the role of Jag1 in the bile
duct developmental abnormalities seen in ALGS, we previously
created a Jag1 conditional knockout mouse model [4]. Conditional
ablation of Jag1 in hepatoblasts results in normal bile duct
development, but mice heterozygous for the Jag1 conditional and
null alleles demonstrate abnormalities in postnatal bile duct
growth and remodeling, with portal expansion and increased
numbers of malformed bile ducts. In this study we report the
results of microarray analysis and identify genes and pathways
differentially expressed in the Jag1 conditional/null livers as
compared with littermate controls.
In the initial microarray analysis, we found that many of the
genes up-regulated in the Jag1 conditional/null mutant livers were
related to extracellular matrix (ECM) interactions, cell adhesion
and cell migration. One of the most highly up-regulated genes was
Ddr1, encoding a receptor tyrosine kinase (RTK) belonging to a
large RTK family. Ddr1 is unusual in that it is activated by various
collagen ligands as opposed to the classical RTK activation via
soluble growth factors [5], and receptor activation by extracellular
collagen might provide a mechanism for cell-to-ECM communi-
cation [6]. Information from published literature regarding Ddr1
structure and function led us to hypothesize that Jag1 and Ddr1
might interact in the extracellular matrix during normal bile duct
development and remodeling. First, reported functions of Ddr1
include cell growth, migration, adhesion and branching tubulo-
genesis [5,7–9], all properties that are known to be crucial for the
normal growth and remodeling of bile ducts. In addition, loss of
Jag1 or Ddr1 in a mouse model leads to similar inner ear
phenotypes. Ddr12/2 mice exhibit hearing loss by 2 months of
age as a result of progressive deterioration of the sensory
epithelium within the organ of Corti, as well as morphological
defects in the cells that make up the stria vascularis including strial
cells, basal cells, marginal cells and intermediate cells. Overall,
Ddr1 function is thought to be essential for maintaining tissue
architecture and controlling collagen deposition in the inner ear
[8]. The Notch ligand Jag1 also plays a role in inner ear
development of the mouse [10]. The headturner (Htu) mouse, a
Jag1 loss-of-function mutant, displays a reduction in the number of
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outer hair cells in the organ of Corti as well as a significant
increase in the number of inner hair cells [10]. Finally, a recent
study has identified Notch1 as a direct target of collagen-mediated
Ddr1 activation [11]. Up-regulation of Hes1 was demonstrated in
breast cancer cells as well as colorectal carcinoma cells, indicating
canonical Notch signaling is activated through this interaction
[11].
In this study, we report the results of microarray analyses to
identify differentially expressed genes and pathways in Jag1
conditional/null livers, which reveal up-regulation of many genes
related to fibrosis and ECM interactions. In addition, we present
protein expression data showing extensive co-localization of Jag1
and Ddr1 in bile ducts and blood vessels in postnatal liver. Finally,
co-immunoprecipitation of the proteins provides evidence for a
novel protein interaction between Jag1 and Ddr1.
Materials and Methods
Mice and Breeding
Genetic strains used in these experiments include Jag1loxP [4],
Jag1dDSL [12], and the Alfp-Cre transgenic line [13]. The Jag1loxP
and Alfp-Cre mice were initially maintained on a C57Bl6/SvEv
background, and now have been backcrossed to C57Bl/6J for
.10 generations. The Jag1dDSL mice were maintained on a
C57Bl/6J background (backcrossed.10 generations). Genotyping
for all mice was performed by PCR analysis using genomic DNA
isolated from the tail tip of weanling mice. All procedures
involving mice were conducted in accordance with federal
guidelines and approved Institutional Animal Care and Use
Committee protocols. All animals received humane care according
to the criteria outlined in the ‘‘Guidelines for the Care and Use of
Laboratory Animals.’’
Ethics Statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol was approved by the Institutional Care and Use
Committee at The Children’s Hospital of Philadelphia (Approval
number 2010-11-431). All attempts were made to minimize
suffering.
Microarray Analysis
RNA was generated from 3 Jag1 conditional/null mutant adult
liver samples, each with a littermate control. Samples were
obtained from mice at 12 weeks, 8 weeks and 4 weeks of age.
Biotin-labeled cRNA probes were synthesized and hybridized to
AffymetrixH Mouse Genome 430A 2.0 GeneChip Arrays. Data
were analyzed with the ArrayAssist software (Stratagene) to
generate GC-RMA absolute expression values, which were log-
transformed and subjected to a t-test to identify differentially-
expressed candidate genes. Student t-test was performed between
the 2 groups of samples (n = 3 for mutants and controls) for each
probe set on the array. Genes with a fold change greater than or
equal to 2.5 and an uncorrected p-value less than 0.05 were
selected for further study. Data were also analyzed by Spotfire and
Ingenuity Pathway Analysis. The microarray dataset has been
submitted to Gene Expression Omnibus with accession number
GSE46577.
PCR Array Analysis
In order to validate the results of the microarray experiment,
custom PCR arrays (SA BiosciencesH, Valencia, CA) were
designed, including 8 genes of interest identified as being
differentially expressed in the mutant liver samples by the criteria
listed above (see Table 1 for a complete gene list and Table 2 for
genes included on the custom array) and Hprt as a housekeeping
gene. RNA and cDNA were prepared from Jag1 conditional/null
and control mouse livers obtained at 4, 8 and 12 weeks. Changes
in gene expression were calculated using the DDCT method, and
results expressed as fold change relative to selected housekeeping
genes. Samples from each mutant group were compared to their
respective littermate controls.
Differential gene expression was also assessed between mutant
and control livers using the Extracellular Matrix and Adhesion
Molecule PCR Array (SA BiosciencesH, Valencia, CA). This real
time PCR-based array measures expression of 84 ECM-related
genes. RNA and cDNA were prepared from Jag1 conditional/null
and control mouse livers obtained at 12–16 weeks (n = 3) and 4
weeks of age (n = 3). Changes in gene expression were calculated
using the DDCT method, and results expressed as fold change
relative to selected housekeeping genes. Samples from each mutant
group were compared to averages of controls in all age groups
(n = 8).
Sirius Red Staining
Livers were collected and fixed in buffered formalin and
paraffin embedded, followed by sectioning at 5 mm-thickness.
Sirius Red staining was performed as in [14].
Immunofluorescence
Livers were collected at appropriate time points and embedded
in OCT compound, snap frozen and stored at 280uC. Immuno-
fluorescent staining was performed on 5 mm frozen sections of
mouse liver. Slides were fixed in cold acetone and washed in PBS.
Sections were incubated at room temperature in 0.25% triton-X
for antigen retrieval and blocked with Pro-block from ScyTek
laboratories (Logan, UT). Primary antibodies were applied at
appropriate dilutions and slides were incubated from 2 hours to
overnight. Jag1 sc-6011 from Santa Cruz Biotech was used at 1:50
dilution, Ddr1 sc-532 also from Santa Cruz Biotech was used at
1:100 dilution and CK19 TROMA-III antibody (Developmental
Studies Hybridoma Bank, University of Iowa) was used at 1:75
dilution. Slides were washed in PBS and incubated with secondary
antibodies for 1 hour at room temperature in darkened conditions.
Secondary antibodies used were DylightH 649-conjugated donkey
anti-goat at a dilution of 1:400, Cy2-conjugated donkey anti-rat at
a dilution of 1:400 and Cy3-conjugated donkey anti-rabbit at a
dilution of 1:600 (all from Jackson Immunoresearch, West Grove,
PA). Nuclei were stained with DAPI for 20 seconds. Finished
specimens were viewed with the Olympus BX-51 fluorescent
microscope (Center Valley, PA).
Co-immunoprecipitation and Western Blot
Immunoprecipitation was performed using the Co-Immuno-
precipitation kit from PierceH ThermoScientific (Rockford, IL).
Antibodies were first de-salted and cleaned using the Pierce
antibody clean–up kit. The antibodies were then immobilized
through the covalent coupling onto an amine-reactive resin. Liver
lysates were made using PBS with 5 mM EDTA, 1 mM CaCl2,
0.02% sodium azide plus appropriate protease- and phosphatase-
inhibitors. Approximately 200 mg of lysate per antibody were pre-
cleared using a deactivated control resin, supplied by the
manufacturer, by incubating for 1 hour at 4uC. Binding of target
and prey proteins were carried out at the same temperature
overnight. Bound products were eluted following several washes to
remove unbound proteins. Western analysis followed to identify IP
and Co-IP products.
Relationship between Jag1 and Ddr1 in Mouse Liver
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The Jag1 sc-6011 and Ddr1 sc-532 rabbit antibodies manufac-
tured by Santa Cruz Biotechnology, Inc (Santa Cruz, CA) were
used at a 1:200 dilution for western blots. Approximately 25 mg of
each antibody was coupled to the AminoLink resin (PierceH
ThermoScientific, Rockford, IL). In addition to the proteins of
interest, an irrelevant antibody (SC-324 rabbit polyclonal anti-
Tie2, Santa Cruz Biotechnology, Santa Cruz, CA) was also
coupled and used as a negative control in the western analysis.
Jag1 Real-time PCR on Whole Newborn Liver
Total RNA was prepared from whole liver newborn mutant and
control livers. cDNA was prepared from 4 mg of total RNA using
the high capacity RNA-to-cDNA kit from Applied Biosystems
(Carlsbad, CA). Assuming 100% conversion of RNA to cDNA,
100 ng of cDNA was used per 20 ml PCR reaction. Each sample
was prepared in quadruplicate using TaqMan Gene Expression
assays for the housekeeping gene, Hprt1 (Mm00446968_m1) as
well as for Jag1 (Mm00496904_m1). The Jag1 probe is a made-to-
order probe that encompasses the region of the targeted Jag1
deletion including exons 4 and 5. The plates were run using an
Applied Biosystems 7300/7500 Real-Time PCR Standard System
using the default program of 50 degrees for 2 minutes, 95 degrees
for 10 minutes and 40 cycles of 95 degrees for 15 seconds, 60
degrees for 1 minute. Data were analyzed using DDCT method
with Applied Biosystems 7500 Real-Time PCR System Software
v1.4.
Results
Gene Expression Analysis Reveals Upregulation of
Fibrosis-related Genes in Mutant Livers
After our initial studies identified abnormalities in postnatal bile
duct growth and remodeling in mice heterozygous for the Jag1
conditional and null alleles, we sought to characterize differentially
Table 1. Genes Up-regulated in Mutant Liver Samples, with Fold Change .2.5.
Unigene Gene Symbol Gene Title Fold Change
Mm.29798 Cd34a* CD34 antigen 5.9085
Mm.286834 Bicc1 bicaudal C homolog 1 (Drosophila) 5.5558
Mm.182785 Emp1* epithelial membrane protein 1 5.5109
Mm.28935 Dptb* dermatopontin 5.3057
\N LOC672274* similar to Transcription factor SOX-4 4.4639
Mm.10760 Osmrc oncostatin M receptor 4.1651
Mm.7562 Col6a3b procollagen, type VI, alpha 3 4.0085
Mm.260227 Pak1 p21 (CDKN1A)-activated kinase 1 3.9983
Mm.18888 Lumb lumican 3.7683
Mm.2408 C3ar1* complement component 3a receptor 1 3.4893
Mm.250492 Loxl1b lysyl oxidase-like 1 3.4667
Mm.5021 Ddr1d discoidin domain receptor family, member 1 3.4395
Mm.4146 Pdgfrbc* platelet derived growth factor receptor, beta 3.4275
Mm.211535 Olfml3 olfactomedin-like 3 3.4268
Mm.252321 Synpo synaptopodin 3.4033
Mm.42163 Casp12* caspase 12 3.3781
Mm.112933 Adamts5e a disintegrin-like and metallopeptidase/thrombospondin 3.3192
Mm.4691 Nid1b nidogen 1 3.3091
Mm.200916 Gpx3 glutathione peroxidase 3 3.1160
\N LOC637870* similar to Nedd4 WW binding protein 4 3.0118
Mm.20897 Clca1* chloride channel calcium activated 1 2.9732
Mm.432071 Gdf10* growth differentiation factor 10 2.9487
Mm.221403 Pdgfrac* platelet derived growth factor receptor, alpha 2.9136
Mm.13787 Cp* ceruloplasmin 2.8745
Mm.292100 Fgl2* fibrinogen-like protein 2 2.6800
Mm.7214 Anxa3 annexin A3 2.6550
Mm.206505 Timp2e tissue inhibitor of metalloproteinase 2 2.6139
Mm.10125 Ift81* intraflagellar transport 81 homolog 2.5475
acell adhesion,
bECM structural proteins,
cFibrosis-related receptor,
dECM interacting proteins,
eECM remodeling proteins.
*genes with p-values,or = 0.01.
Microarray analysis of Jag1 conditional/null adult mouse livers as compared to controls. Genes with fold changes greater than 2.5 and uncorrected p-values of,0.05 are
listed and show expression increases in genes regulating extracellular matrix interactions and remodeling as well as cell adhesion and fibrosis.
doi:10.1371/journal.pone.0084383.t001
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expressed genes and pathways in mutant and control mouse livers
[4]. We hypothesized that specific genes and pathways would be
up- or down-regulated in the mutant mouse livers, and that the
identification of these genes would improve our understanding of
the pathways involved in postnatal bile duct growth and
remodeling, as well as elucidate potential Notch pathway
interactions. In order to assess global changes in gene regulation
across different time points, we elected to study gene expression by
microarray analysis in Jag1 conditional/null mouse livers at 4, 8
and 12 weeks of age, as compared with littermate control samples.
Biotinylated probes were generated for each sample and hybrid-
ized to AffymetrixH Mouse Genome 430A 2.0 GeneChip Arrays
as described in detail in Materials and Methods. The results of this
analysis are presented in Table 1.
Table 1 lists genes found to have increased expression levels in
the mutant liver samples compared to controls, with a fold change
greater than or equal to 2.5, and an uncorrected p-value of ,0.05.
Interestingly, many of the genes identified in this analysis are
related to fibrosis, extracellular matrix interactions and remodel-
ing, or cell adhesion, all of which are important in the process of
bile duct remodeling. For example, CD34, up-regulated in the
mutant liver samples with a fold change of 5.9, encodes a cell
surface glycoprotein that functions as a cell-cell adhesion factor
[15]. Similarly, Dpt (fold change 5.3) encodes dermatopontin, an
extracellular matrix protein that may function in cell-matrix
interactions and matrix assembly. Other up-regulated genes
include those encoding components of the ECM and basement
membrane (Col6a3 and Nid1), as well as those known to bind
collagen, such as Ddr1 and lumican. In order to validate the results
of the microarray, we designed a custom PCR array including
eight of the most highly up-regulated genes and Hprt as a
housekeeping gene for normalization (Table 2). We chose eight of
the top twenty upregulated genes to study further on the PCR
array based on their predicted functions in cell adhesion, ECM
structure or interaction, and fibrosis (Tables 1 and 2). By using the
PCR array approach as opposed to individual real time PCR
assays, we were able to validate our findings in a single
experiment. Using the same 4, 8 and 12-week samples as those
tested on the microarray, the PCR array showed upregulation in
all 8 genes with similar fold changes, and reached statistical
significance for 3 of the genes (CD34, Dpt and Lum; p,0.05). We
also examined differential expression of these 8 genes specifically
at 4 weeks of age (n = 3), and found that all of the genes were up-
regulated in the mutant samples with 6 of the 8 attaining statistical
significance with p-values ,0.05. Of interest, Ddr1 was the most
highly expressed gene at 4 weeks of age, with a fold change of 6.74
and a p-value of 0.007. Ddr1 protein levels are also increased in
the mutant livers at 4 weeks age as compared with controls
(Figure 1).
Given the increased expression of fibrosis- and ECM-related
genes in the Jag1 conditional/null liver samples, we assayed for the
presence of fibrosis in mutant and control livers at postnatal time
points between 4 and 12 weeks of age (Figure 2). At 4 weeks of age,
Sirius Red staining demonstrates significant expansion of the
portal tracts in the mutant liver with clear bridging fibrosis
(Figure 2A) as compared with the littermate control (Figure 2B).
Sirius red staining at earlier stages shows that fibrosis is detectable
in the mutant livers as early as 2 weeks of age (data not shown). At
8 weeks of age, the degree of fibrosis in the mutant livers is less
severe than that seen at 4 weeks of age (Figure 2C). By 12 weeks of
age, the fibrosis appears to be resolving in the mutant livers, with
mildly expanded portal tracts and a few thin bands of connective
tissue extending between portal tracts (Figure 2E). This is in
keeping with our prior finding of mild portal expansion at 12
weeks of age in the mutant livers [4]. At both 8 and 12 weeks of
age, control livers show no significant fibrosis (Figure 2D and F). In
order to investigate the striking early onset of hepatic fibrosis at 4
weeks of age in the Jag1 conditional/null mutant animals, we
performed PCR array analysis specifically for genes related to the
extracellular matrix (ECM Array, SA Biosciences). Of the 84
ECM-related genes included on the array, 24 were significantly
up-regulated in the Jag1 conditional/null mutant livers at 4 weeks
of age with p-values ,0.05 (9 with p-values ,0.01, Table 3).
Highly up-regulated genes include Col1a1 and Vcan, both encoding
structural proteins within the ECM. E-selectin (fold change 18.4) is
a cell adhesion molecule expressed only on cytokine-activated
endothelial cells and involved in inflammation, indicating global
liver injury. In addition, elevated expression of multiple matrix
metallopeptidases indicates active matrix remodeling. Only one
gene, Ecm1, encoding Extracellular Matrix Protein 1, is signifi-
cantly downregulated with a fold change of24.06. Ecm1 has been
reported to inhibit the proteolytic activity of Mmp9 [16]; therefore
Table 2. Validation of Microarray Data.
Microarray Data PCR Array Data PCR Array Data
4,8,12 week samples 4,8,12 week samples 4 week samples only
Gene
Symbol
Fold
Change
Fold
change p-value
Fold
Change p-value
CD34 5.91 3.36 0.03* 4.61 0.04*
Ddr1 3.44 3.85 0.13 6.74 0.007**
Dpt 5.31 3.33 0.03* 3.89 0.02*
Loxl1 3.47 3.99 0.07 4.31 0.02*
Lum 3.77 3.29 0.04* 4.81 0.04*
Nid1 3.31 3.30 0.15 3.15 0.03*
Osmr 4.17 2.33 0.20 3.61 0.07
Pdgfrb 3.43 2.69 0.09 2.63 0.06
A custom PCR array was used to validate the fold changes found in the original
microarray experiment. At the 4 week time point, 6 of the 8 genes investigated
reached statistical significance, indicating the increased severity of the
phenotype at the earlier time point. Ddr1 was the most highly up-regulated
gene found with the most statistically significant p-value, thus prompting
further investigation of the possible relationship between Jag1 and Ddr1.
(* = p#0.05; ** = p#0.01).
doi:10.1371/journal.pone.0084383.t002
Figure 1. Ddr1 protein expression is increased in mutant liver
at 4 weeks of age. A. Immunofluorescence staining shows increased
expression of Ddr1 protein in the periportal region of the Jag1
conditional/null mouse liver at 4 weeks of age. Arrows depict Ddr1
protein expression in the portal vein endothelium. B. In control liver,
Ddr1 protein staining is visible in the arteries (a), but to a lesser extent
in the peri-portal area. (Scale bar in [B] = 25 m for [A] and [B]).
doi:10.1371/journal.pone.0084383.g001
Relationship between Jag1 and Ddr1 in Mouse Liver
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its downregulation may be in keeping with the overall activation of
matrix metallopeptidases and other matrix remodeling proteins in
our model. Interestingly, by 12 to 16 weeks of age, gene expression
levels had returned to baseline, suggesting that wound repair and
remodeling were complete (Table 3).
In order to characterize the time course of Jag1 expression in
the Jag1 conditional/null mutant livers, we performed real time
PCR analysis on whole liver samples between newborn and 4
weeks of age (Figure 3). At the newborn timepoint, Jag1 expression
was significantly downregulated in the mutant livers with a fold
change of 24.71 (p = 0.002), in keeping with ablation of Jag1 from
hepatoblasts. Similarly, at 2 weeks of age, Jag1 expression is
diminished in the mutant livers with a fold change of 23.75
(p = 0.0006). By 3 and 4 weeks of age, Jag1 expression remains
decreased in the mutant livers but the values are no longer
statistically significant. This finding correlates temporally with the
onset of fibrosis and proliferation of other cell types that are able to
express Jag1 because they are not derived from hepatoblasts.
Jag1 and Ddr1 Interaction in Postnatal Liver
Given that Ddr1 was one of the most highly up-regulated genes
in the Jag1 conditional/null mutant livers, and the fact that the
Figure 2. Sirius Red staining demonstrates hepatic fibrosis in Jag1 conditional/null livers. A. Significant portal expansion with bridging
fibrosis is visible in the Jag1 conditional/null mutant liver at 4 weeks of age. B. Control liver does not show fibrosis at 4 weeks of age. C. Portal
expansion is less prominent in the mutant liver at 8 weeks of age, but bridging fibrosis is still present in some area. D. Control liver shows no fibrosis
at 8 weeks of age. E. At 12 weeks of age, fibrosis is improving in the Jag1 conditional/null mutant livers. F. Control liver at 12 weeks of age shows no
fibrosis. (Scale bar in [F] = 100 m for [A] through [F]).
doi:10.1371/journal.pone.0084383.g002
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literature supports overlapping functions for these two genes, we
investigated the expression patterns of Jag1 and Ddr1 in normal
postnatal liver by immunofluorescence, and found that these two
proteins are extensively co-expressed. In the newborn liver, both
Jag1 and Ddr1 are expressed in biliary cells (Figure 4A, box),
which are still incompletely remodeled and resemble the ductal
Table 3. Timecourse of Extracellular Matrix & Adhesion PCR Array Gene Expression.
Gene Symbol Gene Title Fold Change
12–16 weeks 4 weeks p-value*
Cd44 CD44 antigen 1.19 2.78 0.044
Cdh3 Cadherin 3 21.38 3.69 0.007
Col1a1 Collagen, type I, alpha 1 21.26 22.14 0.020
Col3a1 Collagen, type III, alpha 1 22.00 7.95 0.051
Vcan Versican 21.18 15.12 0.003
Ecm1 Extracellular matrix protein 1 21.38 24.06 0.003
Fbln1 Fibulin 1 1.02 4.38 0.031
Icam1 Intercellular adhesion molecule 1 1.30 2.88 0.032
Itgam Integrin alpha M 1.47 5.52 0.006
Itgax Integrin alpha X 1.91 5.35 0.007
Mmp11 Matrix metallopeptidase 11 1.03 3.20 0.005
Mmp13 Matrix metallopeptidase 13 1.65 6.32 0.020
Mmp15 Matrix metallopeptidase 15 1.72 3.33 0.046
Mmp2 Matrix metallopeptidase 2 1.13 8.26 0.023
Mmp3 Matrix metallopeptidase 3 21.75 5.39 0.052
Mmp7 Matrix metallopeptidase 7 2.34 4.61 0.023
Mmp8 Matrix metallopeptidase 8 1.83 17.98 0.000
Mmp9 Matrix metallopeptidase 9 1.74 5.56 0.018
Sele Selectin, endothelial cell 1.16 18.42 0.007
Sell Selectin, lymphocyte 1.57 3.31 0.053
Spp1 Secreted phosphoprotein 1 (Osteopontin) 21.68 8.93 0.001
Thbs1 Thrombospondin 1 1.17 8.64 0.016
Thbs2 Thrombospondin 2 1.29 4.13 0.019
Thbs3 Thrombospondin 3 1.46 5.34 0.033
Tnc Tenascin C 21.43 10.82 0.009
*p-values listed are for the 4 week data only.
Real-time PCR was employed using the Extracellular Matrix & Adhesion molecules PCR Array to investigate the changes in gene expression related to fibrosis and injury
over time. The data support a repair mechanism is likely active between the peak fibrotic phenotype at 4 weeks of age and 12–16 weeks of age.
doi:10.1371/journal.pone.0084383.t003
Figure 3. Time course of Jag1 gene expression in Jag1 conditional/null mouse liver samples. Measurement of Jag1 expression in whole
mouse liver by real time PCR reveals that Jag1 expression is significantly decreased in Jag1 conditional/null mutant livers at newborn and 2 week time
points. At 3 and 4 weeks of age, Jag1 expression is not significantly decreased in whole liver, possibly corresponding to increased Jag1 expression in
other cell types within the liver.
doi:10.1371/journal.pone.0084383.g003
Relationship between Jag1 and Ddr1 in Mouse Liver
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plate in appearance. By 1 week of age, both Jag1 and Ddr1 are
expressed in the portal mesenchyme (Figure 5A, C, arrows), which
is in very close proximity to the bile duct (Figure 5E, arrow). Both
proteins are also expressed in the hepatic artery (HA; Figure 5B,
D, F) and the bile duct (Figure 5F). At a higher magnification, Jag1
and Ddr1 protein are localized to the cell junctions within the bile
duct (Figure 5G, H, I). Strong expression of both proteins
continues at 2 weeks in the hepatic artery and bile ducts (Figure 6A,
B, C). Specifically, Jag1 and Ddr1 are co-localized at cell junctions
between biliary cells (Figure 6A, B, arrow). The extensive co-
expression and subcellular co-localization of Jag1 and Ddr1
suggests that these two proteins may interact directly in the
postnatal liver.
In order to demonstrate interaction between Jag1 and Ddr1, we
performed immunoprecipitation and co-immunoprecipitation
experiments using whole liver lysate from C57Bl/6J mice at 2
weeks of age. In the immunoprecipitation experiment, Ddr1-
coupled resin pulled down the 63 kD alpha subunit and the 54 kD
beta subunit of the Ddr1 protein (Figure 7A). The same two bands
were visible when Jag1-coupled resin was used in a co-
immunoprecipitation experiment, probing the membrane with
Ddr1 antibody (Figure 7B). In the control lane (Figure 7C), an
irrelevant Tie-2 antibody was used for the immunoprecipitation
and the membrane was again probed with Ddr1 antibody, with no
visible bands. In the opposite experiment, Ddr1-coupled resin was
used to co-immunoprecipitate Jag1. Probing the membrane with
Jag1 antibody did not demonstrate a band consistent with full
length Jag1, but did reveal two smaller bands (,40 kD and
,52 kD), consistent with Jag1 degradation products ([17]; data
not shown). To date, collagen proteins are the only known ligands
for Ddr1. Further studies will be required to determine whether
Jag1 can act as a functional ligand for Ddr1.
Discussion
In this study, we have identified up-regulated expression of
ECM- and fibrosis-related genes in Jag1 conditional/null mouse
livers by microarray analysis. These findings were validated by real
time PCR on a custom PCR array, and expanded analysis using a
targeted array showed widespread increases in expression of
ECM-related genes in mutant livers at 4 weeks of age.
Interestingly, these changes in gene expression resolved completely
by 12 weeks of age. In addition, we have identified a novel protein
interaction between Jag1 and Ddr1, which may have relevance to
tissue remodeling and repair.
As we interrogated the literature for information about the
differentially expressed genes identified in the microarray exper-
iment, several lines of evidence suggested that Ddr1 would be an
intriguing candidate for in depth study. First, Ddr1 encodes a
receptor tyrosine kinase activated directly by collagen ligands,
implying a role in cellular communication with the extracellular
matrix. In fact, Ddr1 has been implicated in cell migration and
ECM remodeling during branching tubulogenesis in mammary
gland and bronchial development [5], both of which share
similarities with biliary morphogenesis. Ddr1 has not been studied
extensively in the liver, but overexpression of Ddr1 has been
detected in diseased human liver [18] and in early recurrence of
hepatocellular carcinoma [19]. Interestingly, Ddr1 has been
implicated in a number of different human cancers, possibly
enhancing cell proliferation via direct activation of canonical
Notch1 signaling [11]. Also of interest is the finding that Ddr1 was
identified as a potential cell surface marker for hepatic progenitors
in a microarray study of rat liver [20]. Furthermore, mice lacking
Ddr1 demonstrate inner ear defects similar to those seen in the
Headturner mouse (Htu), a Jag1 loss of function mutant [8,10].
Finally, Ddr1 was highly and significantly upregulated in the Jag1
conditional/null mutant livers at 4 weeks of age, the timepoint
with the most dramatic phenotype of fibrosis and cellular unrest.
The extensive co-localization of Jag1 and Ddr1 in postnatal liver,
combined with co-immunoprecipitation data indicating protein-
protein interaction and a shared domain between Jag1 and the
known Ddr1 ligands, all point towards a novel protein interaction.
Additionally, Ddr1 has been shown to activate canonical Notch
signaling [11], suggesting that upregulation of Ddr1 might
compensate for the loss of Jag1 in our conditional knockout
model in the postnatal period. Given the temporal-spatial
expression patterns of these two genes, it is likely that they are
actively involved during biliary and arterial development and
remodeling.
Precedent exists in the literature for Jag1 to interact with
proteins outside the canonical Notch signaling pathway. For
example, the ECM glycoprotein MAGP-2 has been found to
interact with Jag1 and induce its shedding from the cell surface
[21]. In addition, MAGP-2 promotes angiogenesis by antagoniz-
ing Notch signaling in endothelial cells through effects on Jag1
[22]. Thus, MAGP-2 is able to directly modulate Notch signaling
via Jag1, and to a lesser extent, other Notch pathway ligands. The
effect of the interaction between Jag1 and Ddr1 is as yet
uncharacterized, but it is possible that Ddr1 may induce shedding
of soluble Jag1 protein into the extracellular matrix. Soluble Jag1
has been found to have effects on cellular differentiation in
epithelial keratinocytes [23]. Alternatively, Jag1 may act as an
alternative ligand for Ddr1, with resultant effects on expression of
downstream genes. Collagen, the primary ligand for Ddr1, has
also been shown to interact directly with the Notch ectodomain to
repress canonical Notch signaling [24]. It is certain that the Jag1/
Ddr1 interactions are complex and likely to result in a myriad of
downstream alterations in gene expression within the microenvi-
ronment of the extracellular matrix. Further studies will be
required to fully elucidate these novel functions.
In this study, we demonstrate marked upregulation of ECM-
related genes in the Jag1 conditional/null mutant livers at 4 weeks
of age that is completely resolved by 12 weeks of age (Table 3). In
agreement with this finding, Sirius red staining of liver tissue in
these animals shows portal expansion progressing to bridging
fibrosis by 4 weeks of age (Figure 2), but at later time points fibrosis
is minimal [4]. These data suggest that the loss of Jag1 early in
development results in a cascade of events causing activation of
pro-fibrogenic pathways, but the process does not appear to be
Figure 4. Jag1 and Ddr1 are co-expressed in newborn mouse
liver. A. Immunofluorescence staining shows co-localization of Jag1
(blue) and Ddr1 (red) proteins in immature biliary cells surrounding the
portal vein in C57Bl/6J mouse liver. B. Cytokeratin 19 staining (CK19,
green) identifies the cells expressing Jag1 and Ddr1 as being of biliary
origin. (Scale bar in [B] = 25 m for [A] and [B]).
doi:10.1371/journal.pone.0084383.g004
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Figure 5. Jag1 and Ddr1 are co-expressed in mouse liver at 1 week of age. A, C, E. Jag1 and Ddr1 are co-expressed in the portal
mesenchyme in C57Bl/6J mouse liver at 1 week of age, in close proximity to the bile duct (arrow). B, D, F. Jag1 and Ddr1 are also co-localized in the
hepatic artery at 1 week of age in the mouse liver. G, H, I. High magnification view of the bile duct (boxed area in F) shows expression of Jag1 and
Ddr1 in the intercellular junctions (arrows, G and H). (Scale bar in [I] = 25 m for [A] through [I]).
doi:10.1371/journal.pone.0084383.g005
Relationship between Jag1 and Ddr1 in Mouse Liver
PLOS ONE | www.plosone.org 8 December 2013 | Volume 8 | Issue 12 | e84383
progressive. One possible explanation for the resolution of fibrosis
over a series of weeks is that Jag1 expression levels are increased in
other cell types, as shown by the gradual increase in Jag1
expression over the first 4 weeks in the mutant animals (Figure 3).
Both Jag1 and Ddr1 have been identified as key components of
wound healing and smooth muscle cell migration [7,25,26].
Specifically, Jag1 expression increases upon vascular injury, and a
soluble form of Jagged1, presumed to act in a dominant negative
fashion, had a negative effect on cell-matrix adhesion and cell
migration in an in vitro injury model [26]. Cadherin-mediated
intercellular junctions and focal adhesion complexes were also
altered in the cells overexpressing soluble Jagged1. Interestingly,
both Jag1 and Ddr1 are expressed in biliary cell junctions in
mouse liver at 1 and 2 week timepoints (Figures 5 and 6). In
addition, Ddr1 has been found to play a crucial role in smooth
muscle cell migration, proliferation and neointimal thickening
following arterial injury [7]. Ddr1 was also found to enhance
epithelial repair in a human bronchial epithelial cell model
through increased expression of matrix metalloproteinases [27].
Jag1 and Ddr1 are also both involved in regulating E-cadherin, a
gene known to affect cell migration, invasion and epithelial-to-
mesenchymal transition [28–30]. It is therefore possible that Jag1
and Ddr1 may play a role in reversal of fibrosis and downreg-
ulation of ECM-related genes at later timepoints in our mutant
model.
In summary, we have presented microarray results, expression
data and co-immunoprecipitation experiments that suggest a novel
protein interaction between the Notch ligand Jag1 and the
receptor tyrosine kinase Ddr1. The nature of this interaction and
its functional consequences are as yet unclear, but further studies
will be required to investigate the implications for bile duct
remodeling and repair of liver injury.
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Figure 6. Jag1 and Ddr1 are co-localized in hepatic artery and
bile duct at 2 weeks of age. A, B, C. Ddr1 (red) and Jag1 (blue) are
expressed in hepatic artery in the mouse liver at 2 weeks of age (HA,
panel C). While Jag1 is highly expressed in the endothelium, Ddr1
expression appears to be confined to the smooth muscle wall of the
blood vessel. Ddr1 and Jag1 are both expressed in areas of intercellular
junctions within bile ducts (arrows, panels A and B). (Scale bar in
[C] = 25 m for [A] through [C]).
doi:10.1371/journal.pone.0084383.g006
Figure 7. Co-immunoprecipitation of Jag1 and Ddr1. A.
Immunoprecipitation of Ddr1 reveals two primary bands corresponding
to the Ddr1 subunits, visualized at 54 kDa and 63 kDa. These proteins
represent the alpha-(membrane-bound) and beta-subunits (soluble) of
Ddr1. B. Coupling of Jag1 antibody to the aminolink resin and probing
of western blot with Ddr1 antibody reveals co-immunoprecipitation of
Jag1 and Ddr1 in mouse liver, with strong bands visualized at 54 kDa
and 63 kDa. C. As a control experiment, Tie-2 antibody was coupled to
the aminolink resin. Probing the western blot with Ddr1 antibody
reveals no specific bands.
doi:10.1371/journal.pone.0084383.g007
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